BGI Global Economic Services
Sentis - Molecular Diagnostics

BGI SENTISTM Cancer+Discovery

The Power Of Knowing

CAP Accredited

The panel provides one of the most comprehensive and accurate Next Generation Sequencing (NGS) testing solution for the identification of

hospital Clinically actionable mutations (somatic & genetic variants)

hospital Discovery of novel variants (with important functions in cancer)

Whole Exon Coverage

Major genetic alterations

FDA & NCCN guideline drug recommendation

Why choose us?

Comprehensive

Robust

Affordable

For more information on BGI’s Cancer+ Discovery Test :